Table 3. Adverse events.
Adverse events (%) | All grades n (%) | Grade ≥ 3 n (%) |
---|---|---|
Fatigue | 12 (63.15) | 0 (0) |
Headache/Dizzy | 3 (15.79) | 0 (0) |
Diarrhea | 11 (57.89) | 1 (5.26) |
Anorexia | 9 (47.37) | 0 (0) |
Vomit | 0 (0) | 0 (0) |
Stomachache | 0 (0) | 0 (0) |
Nausea | 4 (21.05) | 0 (0) |
Alimentary tract hemorrhage | 0 (0) | 0 (0) |
Dysphagia | 0 (0) | 0 (0) |
Pharyngolaryngeal pain | 1 (5.26) | 0 (0) |
Dyspepsia | 6 (31.58) | 0 (0) |
Mucositis oral | 3 (15.79) | 0 (0) |
Dysgensia | 0 (0) | 0 (0) |
HFSR | 17 (89.47) | 1 (5.26) |
Hypertension | 15 (78.95) | 0 (0) |
Proteinuria | 6 (31.58) | 0 (0) |
Elevated transaminase | 1 (5.26) | 0 (0) |
Hyperbilirubinemia | 1 (5.26) | 0 (0) |
Elevated GGT | 0 (0) | 0 (0) |
Alkaline phosphatase | 0 (0) | 0 (0) |
Hypoproteinemia | 2 (10.53) | 0 (0) |
Leukopenia | 0 (0) | 0 (0) |
Neutropenia | 0 (0) | 0 (0) |
Aglobulism | 0 (0) | 0 (0) |
Thrombocytopenia | 5 (26.32) | 0 (0) |
Hoarseness | 1 (5.26) | 0 (0) |
HFSR: hand-foot-skin reaction; GGT: gamma-glutamyl transpeptidase.